TLanceCurrent, the radical company led by health tech investor and former Livongo CEO Glenn Talman, today announced $126 million in Series D funding, valuing the company at $2.2 billion.
The investment round was led by venture capital giant General Catalyst and 7wireVentures, of which Talman is a managing partner. Transcurrent will use the funding to help develop artificial intelligence capabilities across the company, grow its business and pursue acquisitions, Talman told STAT. Transcurrent has raised about $450 million to date.
Founded in 2020, Transcarent is one of the few startups looking to leverage technology to improve care and reduce costs for companies that provide health benefits to their employees. Talman said TransCurrent stands out from other medical navigation and virtual care companies that are also committed to making health care cheaper and more accessible.
This article is exclusive to STAT+ subscribers
Subscribe to STAT+ to unlock this article and get additional analysis of the technologies disrupting healthcare.
Do you already have an account?Login
Do you already have an account?Login
See all plans
Get unlimited access to award-winning journalism and exclusive events.
subscribe
